Technical Analysis for RP - Replicel Life Sciences Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Crossed Above 20 DMA | Bullish | -15.38% | |
| Narrow Range Bar | Range Contraction | -15.38% |
| Alert | Time |
|---|---|
| No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. | |
Free Daily (Stock) Chart Reading
- Earnings date: 2024-05-30
Replicel Life Sciences Inc. Description
RepliCel Life Sciences Inc. is a regenerative medicine company focused on developing autologous cell therapies that treat functional cellular deficits. The Company's product pipeline includes RCT-01-Tendon Repair, RCS-01-Skin Rejuvenation, RCH-01-Hair Regeneration and RCI-02-Dermal Injector. RCT-01 is an autologous cell-based treatment utilizing non-bulbar dermal sheath cells isolated from the hair follicle sheath to treat chronic tendinosis caused by acute and chronic tensile overuse. RCH-01 also utilizes dermal sheath cup cells isolated from the hair follicle to treat androgenetic alopecia. RCI-02 is a dermal injector designed to control intradermal (dermis), subcutaneous (fat) or intramuscular injections. It is designed to support the injection of RCH-01 and RCS-01 cell therapy products. The injector has applications for dermatological procedures requiring injections of specific volumes of material at specific depths, including cellular products, fillers and collagen injections.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pipe Pipeline Science RTT Life Sciences Skin Volume Therapy Organ Systems Collagen Regenerative Medicine Anatomy Cell Therapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.25 |
| 52 Week Low | 0.04 |
| Average Volume | 25,423 |
| 200-Day Moving Average | 0.122 |
| 50-Day Moving Average | 0.075 |
| 20-Day Moving Average | 0.061 |
| 10-Day Moving Average | 0.059 |
| Average True Range | 0.010 |
| RSI (14) | 46.24 |
| ADX | 14.36 |
| +DI | 33.333 |
| -DI | 29.066 |
| Chandelier Exit (Long, 3 ATRs) | 0.041 |
| Chandelier Exit (Short, 3 ATRs) | 0.079 |
| Upper Bollinger Bands | 0.075 |
| Lower Bollinger Band | 0.048 |
| Percent B (%b) | 0.26 |
| BandWidth | 43.719 |
| MACD Line | -0.006 |
| MACD Signal Line | -0.007 |
| MACD Histogram | 0.0006 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.055 | ||||
| Resistance 3 (R3) | 0.055 | 0.055 | 0.055 | ||
| Resistance 2 (R2) | 0.055 | 0.055 | 0.055 | 0.055 | |
| Resistance 1 (R1) | 0.055 | 0.055 | 0.055 | 0.055 | 0.055 |
| Pivot Point | 0.055 | 0.055 | 0.055 | 0.055 | 0.055 |
| Support 1 (S1) | 0.055 | 0.055 | 0.055 | 0.055 | 0.055 |
| Support 2 (S2) | 0.055 | 0.055 | 0.055 | 0.055 | |
| Support 3 (S3) | 0.055 | 0.055 | 0.055 | ||
| Support 4 (S4) | 0.055 |
